Steven D. Freedman M.D., Ph.D.

Beth Israel Deaconess Medical Center

Steven D. Freedman M.D., Ph.D. is Director of the Pancreas Center at Beth Israel Deaconess Medical Center, Chief of the Division of Translational Research, and Professor of Medicine at Harvard Medical School, Boston, Massachusetts. He has played a leadership role in clinical/translational research both at Beth Israel Deaconess Medical Center and at Harvard Medical School through his prior role as the Associate Dean for Clinical and Translational Research and Co-director of the Harvard CTSA (Harvard Catalyst). He is Director of the Grant Review and Support Program (GRASP) of the Harvard Clinical and Translational Science Center, which is a unique longitudinal program that provides project management support and grant writing tools to enhance the transition from the NIH K to R01 grant for junior faculty across the Harvard affiliated hospitals.

Dr. Freedman received his Ph.D. from Yale University School of Medicine in 1981 followed by the M.D. degree at the University of Connecticut in 1986. He completed his residency and fellowship in Gastroenterology at Beth Israel Hospital and has remained on faculty since 1991. Dr. Freedman’s expertise is in exocrine pancreatic disease with a particular focus on pancreatitis and cystic fibrosis. He is an internationally recognized leader in these areas with an extensive research program that encompasses both basic science discovery as well as clinical trials. More recently, he has expanded these research discoveries to the pathogenesis and treatment of Neonatal morbidities. He has also been a leader in identifying the site in the brain where pancreatic visceral pain is represented, has developed molecular signatures of pain using MR Spectroscopy, and has successfully developed pain therapies using Transcranial Magnetic Stimulation. Dr. Freedman has also developed a major focus on health care delivery reform that addresses structuring the doctor-patient encounter to build informed partnerships leading to sustained improvements in health outcomes (Passport to TRUST).

Dr. Freedman has an extensive track record on training the next generation of physician scientists. With the support of the Cystic Fibrosis Foundation, Dr. Freedman has developed and launched a national initiative to train pediatric and adult gastroenterologists across North America in the diagnosis and treatment of the GI manifestations of CF. This 3-year program called DIGEST (Developing Innovative Gastrointestinal Specialty Training) enrolls junior faculty pediatric and adult gastroenterologists, provides salary support, and consists of monthly webinars and scholarly projects as well as development of best practice guidelines. More recently, Dr. Freedman has extended his training initiatives to include his recent appointment as Director of the Beth Israel Deaconess Medical Center Internal Medicine Residency Physician Scientist Track.


Appearances